1. A37 EFFICACY AND SAFETY OF RISANKIZUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH CROHN'S DISEASE: 52 WEEK RESULTS FROM THE PHASE 3 FORTIFY STUDY. (21st February 2022) Authors: Panaccione, R; Ferrante, M; Feagan, B G; Sandborn, W; Panes, J; Peyrin-Biroulet, L; Colombel, J; Schreiber, S; Dubinsky, M; Baert, F; Hisamatsu, T; Neimark, E; Huang, B; Liao, X; Song, A; Berg, S; Duan, W; Pang, Y; Pivorunas, V; Kligys, K Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 5(2022)Supplement 1 Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Changes in Disease Behaviour and Location in Patients With Crohn's Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort. (9th October 2017) Authors: Lo, B; Vester-Andersen, M K; Vind, I; Prosberg, M; Dubinsky, M; Siegel, C A; Bendtsen, F; Burisch, J Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 3(2018:Mar.) Page Start: 265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOP008 Safety of adalimumab in children and adolescents with moderate-to-severe Crohn's disease: interim results of the CAPE registry. (16th January 2018) Authors: Turner, D; Koletzko, S; Winter, H; Baldassano, R; Dubinsky, M; Faubion, W; Hyams, J; Kugathasan, S; Rosh, J; Escher, J; Griffiths, A; Kierkus, J; Russell, R; Heap, G; Arikan, D; Kuehnl, V; Petersson, J; Robinson, A; Ruemmele, F Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S035 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DOP012 Disease demarcation in ulcerative colitis is associated with different patterns of gene expression. (16th January 2018) Authors: Suarez-Farinas, M; Huang, R; Kosoy, R; Irizar, A; Losic, B; Wei, G; Peters, L; Song, W -m; Di Narzo, A; Wang, W; Perrigoue, J; Castillo, A; Rogers, J; Atreja, A; Hurley, A; Mahajan, M; Zhang, B; Stojmirovic, A; Curran, M; Dobrin, R Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S038 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DOP25 Contraceptive method use according to Inflammatory Bowel Disease status among young women in the United States. (30th January 2023) Authors: Brenner, E; Zhang, X; Long, M; Dubinsky, M; Kappelman, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. DOP38 Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1. (21st January 2022) Authors: Vermeire, S; Colombel, J F; Takeuchi, K; Gao, X; Panaccione, R; Danese, S; Dubinsky, M; Schreiber, S; Ilo, D; Finney-Hayward, T; Zhou, W; Phillips, C; Yao, X; Zhou, Q; Loftus, E Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i087 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. DOP50 Effect of upadacitinib on extra-intestinal manifestations in patients with moderate to severe Crohn's disease: data from the CELEST study. (25th January 2019) Authors: Peyrin-Biroulet, L; Danese, S; Louis, E; Higgins, P D R; Dubinsky, M; Cataldi, F; Zhou, Q; Lee, W-J; Kligys, K; Lacerda, A P Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S057 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. DOP70 Crohn's Disease Like Inflammation of The Pouch is a Distinct Type of Pouchitis. (30th January 2023) Authors: Kayal, M; Tankelevich, M; Guo, Y; Fischer, J; Jimenez, D; Canales-Herrerias, P; Livanos, A; Colombel, J F; Dubinsky, M; Faith, J; Ko, H; Mehandru, S Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. DOP82 Achievement of steroid-free remission in patients with moderately to severely active Crohn's Disease during treatment with risankizumab. (21st January 2022) Authors: Schreiber, S W; Cross, R; Panaccione, R; D'Haens, G; Bossuyt, P; Colombel, J F; Louis, E; Dubinsky, M; Kligys, K; Neimark, E; Song, A; Zambrano, J; Cheng, E; Ferrante, M Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. DOP87 The Anti-TL1A Antibody PRA023 Demonstrated Proof-of-Concept in Crohn's Disease: Phase 2a APOLLO-CD Study Results. (30th January 2023) Authors: Feagan, B G; Sands, B; Siegel, C A; Dubinsky, M; Longman, R; Sabinho, J; Laurent, O; Luo, A; Lu, J D; Nguyen, D; Towfic, F; DuVall, A; Woyranowski, M; Al Kharrat, H; McGovern, D P B Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗